Article · 31 Oct 2026
Review articlePublished 10 Mar 2022
A detail study of corona vaccine effect on cancer patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) is highly communicable and pathogenic coronavirus that come out in December 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID 19), which intimidate public health and safety. According to World Health Organization (WHO), infection is known as COVID-19. With the start of the COVID-19 pandemic, 10 vaccines against SARS-CoV-2 have been approved for at least limited use, with over sixty others in clinical trials. This swift achievement has generated excitement and arrives at a time of great need, as the number of COVID-19 cases worldwide continues to rapidly increase. Two vac-cines are currently approved for full use, both built on mRNA and lipid nanotechnology platforms, a success story of mRNA technology 20 years for making. For cancer patients, questions put up for the safety and efficacy of these vaccines in the setting of immune alterations engendered by their therapies. We discuss in this article on leading COVID-19 vaccine candidates and vaccination of patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Onkologia i Radioterapia.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOnkologia i Radioterapia
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Poonam Joshi”
- BylineArticles whose byline prints “Kapil Kalra”
- BylineArticles whose byline prints “Deepika Ghalwan”